Table 4.

PLA2R tissue antigen and serum antibody

PatientTissue PLA2R in First BiopsyTissue PLA2R in Second BiopsySerum PLA2R Antibody (titer)Clinical Status at Time of Serum Sampling
1Not doneNot biopsiedPositive (55 RU/ml)Relapse
2PositivePositivePositive (21.3 RU/ml)Relapse
3Not donePositiveNot checkedSerum PLA2R antibody not checked
4Not doneNot biopsiedPositive (1:160)Relapse
5Not donePositiveNegativeRemission
6Not doneNot stainedNot checkedSerum PLA2R antibody not checked
7Not doneNot stainedNegativeRelapse (had clinical remission same year)
8Not doneNot stainedNegativeRelapse (did not achieve remission)
9Not doneNot stainedNegativeRemission
10Not doneIndeterminateIndeterminateRelapse
11Not doneNot biopsiedPositive (1:20)Relapse
12Not donePositiveNegativeRelapse (had clinical remission same year)
13Not donePositiveNot checkedSerum PLA2R antibody not checked
14Not doneNegativeNegativeRelapse (had clinical remission same year)
15Not doneNot biopsiedPositive (1:80)Relapse
16Not doneNot biopsiedNegativeRelapse (had clinical remission same year)
  • PLA2R, M-type phospholipase A2 receptor.